First Eagle Investment Management
MRTX

First Eagle Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

First Eagle Investment Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-62,813
Closed -$1.98M – 337
2015
Q2 		$1.98M Sell
62,813
-57,099
-48% -$1.68M ﹤0.01% 202
2015
Q1 		$3.52M Buy
119,912
+20,000
+20% +$469K 0.01% 190
2014
Q4 		$1.85M Hold
99,912
– – ﹤0.01% 210
2014
Q3 		$1.75M Hold
99,912
– – ﹤0.01% 217
2014
Q2 		$2M Sell
99,912
-50,000
-33% -$965K ﹤0.01% 219
2014
Q1 		$2.86M Sell
149,912
-237,413
-61% -$4.93M 0.01% 176
2013
Q4 		$6.44M Buy
+387,325
New +$6.62M 0.02% 159

Other funds holding MRTX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VAM
Visium Asset Management New York $955M AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return